Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Coronary heart disease that continues to progress to serious events in patients whose LDL levels have been brought down adequately — called “residual…
NEW YORK (Reuters Health) – Recommendations issued by the European Society of Cardiology emphasize the need to consider the clinical context in interpreting cardiac troponin readings in acute…
NEW YORK (Reuters Health) – Rates of major adverse cardiovascular events (MACEs) are lower in hypertensive patients with coronary artery disease on amlodipine when candesartan is added to…
NEW YORK (Reuters Health) – Very elderly patients with ST-segment elevation MI can do quite well with successful primary percutaneous intervention, as long they aren’t in cardiogenic shock…
NEW YORK (Reuters Health) – When target cholesterol levels are not achieved with statin monotherapy in patients with mixed dyslipidemia, adding fenofibrate can tip the scales favorably. Dr.…
NEW YORK (Reuters Health) – Patients on warfarin need not discontinue treatment when they have a fecal occult blood test (FOBT), as it does not affect the predictive…
NEW YORK (Reuters Health) – Contrary to earlier concerns, the use of ultrasound contrast agents in echocardiography is not associated with an increased incidence of myocardial infarction or…
NEW YORK (Reuters Health) – Cardioversion of atrial fibrillation or flutter to sinus rhythm using ibutilide is more successful and less likely to trigger torsades de pointes when…
NEW YORK (Reuters Health) – Outcomes of percutaneous coronary intervention are just as good when a loading dose of clopidogrel is given in the cath lab just before…
NEW YORK (Reuters Health) – Stents coated with sirolimus (Cypher) and those coated with paclitaxel (Taxus) perform equally well for revascularization of saphenous vein grafts, investigators report. A…
